Nanotechnology and multipotent adult progenitor cells in Reparative Medicine: therapeutic perspectives

被引:0
|
作者
Mazzeo, Angela [1 ]
Clemente Santos, Enrico Jardim [2 ]
机构
[1] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, SP, Brazil
[2] Celltrovet, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2018年 / 16卷 / 04期
关键词
Nanotechnology; Stem cells; Therapeutics;
D O I
10.31744/einstein_journal/2018RB4587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The biology of stem cells is one of the most dynamic and promising fields of the biological sciences, since it is the basis for the development of organisms. Its biological complexity demands efforts from several lines of research aimed mainly at its therapeutic use. Nanotechnology has been emerging as a new field of study, which shows great potential in the treatment of various diseases. This new area of health has been called "Nanomedicine" or "Bionanotechnology", which can be applied in Medicine by transport and drug delivery systems, robotic tools to be used in diagnostic and surgical processes, nanobiomaterials, gene therapies, nanobiomedical devices, among others. Because stem cells and Nanotechnology are two areas of extremely promising science, a new field of study, called "stem cell Nanotechnology", has gradually emerged. In this, Nanotechnology is used to help the stem cells apply their therapeutic potential in the treatment, cure, and repair of the damaged tissues, in an effective and safe way. In this way, stem cell Nanotechnology has generated great interest, since it may result in significant contributions to Regenerative Medicine and tissue engineering. The present work aims to present the state-of-the-art regarding its therapeutic use in Human Medicine.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Multipotent adult progenitor cells
    Sohni, Abhishek
    Verfaillie, Catherine M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (01) : 3 - 11
  • [2] Multipotent adult progenitor cells
    Burns, TC
    Verfaillie, CM
    Low, WC
    Jiang, Y
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 77 - 77
  • [3] Multipotent Progenitor Cells in Regenerative Cardiovascular Medicine
    Lam, Jason T.
    Moretti, Alessandra
    Laugwitz, Karl-Ludwig
    PEDIATRIC CARDIOLOGY, 2009, 30 (05) : 690 - 698
  • [4] Multipotent Progenitor Cells in Regenerative Cardiovascular Medicine
    Jason T. Lam
    Alessandra Moretti
    Karl-Ludwig Laugwitz
    Pediatric Cardiology, 2009, 30 : 690 - 698
  • [5] Multipotent progenitor cells in the adult dentate gyrus
    Gage, FH
    Kempermann, G
    Palmer, TD
    Peterson, DA
    Ray, J
    JOURNAL OF NEUROBIOLOGY, 1998, 36 (02): : 249 - 266
  • [6] Multipotent adult progenitor cells for vascular repair
    Verfaillie, C. M.
    Ross, J.
    Ulloa, F.
    Serafini, M.
    Lutton, A.
    Pauwelyn, K.
    Barajas, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 18 - 18
  • [7] Culture of multipotent adult progenitor cells (MAPCs).
    Jiang, YH
    Breyer, A
    Lien, L
    Blackstad, M
    Verfaillie, C
    BLOOD, 2004, 104 (11) : 641A - 641A
  • [8] Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis
    Singh, Saurabh Pratap
    Jadhav, Sachin Hanumantrao
    Chaturvedi, Chandra Prakash
    Nityanand, Soniya
    REGENERATIVE MEDICINE, 2017, 12 (04) : 377 - 396
  • [9] Plasticity and cardiovascular applications of multipotent adult progenitor cells
    Pelacho B.
    Aranguren X.L.
    Mazo M.
    Abizanda G.
    Gavira J.J.
    Clavel C.
    Gutierrez-Perez M.
    Luttun A.
    Verfaillie C.M.
    Prósper F.
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (Suppl 1): : S15 - S20
  • [10] Multipotent adult progenitor cells for vascular repair.
    Verfaillie, Catherine M.
    Ross, Jeff
    Ulloa, Fernando
    Keirstadt, Susan
    Luttun, Aernout
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2006, 42 : 6A - 6A